Stereotaxis (STXS) Swings to Q3 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq slides over 1% as Alphabet results revive AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- Moderna stock rises on latest cancer vaccine data publication
Stereotaxis Reports 2015 Third Quarter Financial Results
November 3, 2015 4:05 PM EST-Total Quarterly Revenue Increased 5% Year over Year on Improved System and Recurring Revenues- -Total Revenue for First Nine Months Increased 13% Year over Year to $28.5 Million- -System Revenue for First Nine Months Increased 76% Year over Year to $8.2 Million- -Operating Loss Decreased 23% Year over Year and 29% for the First Nine-Month Period--Third Niobe® ES System Shipment to Japan--New System Automation Features Released--Conference Call Today at 4:30 p.m. Eastern Time-
ST. LOUIS, Nov. 03, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ: STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias,... More



